UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X2/3 receptor function and exerts an analgesic effect in pain models

European journal of pharmacology, 2008-07, Vol.589 (1-3), p.98-101

2008

Volltextzugriff (PDF)

Effect of single oral administration of YM598, a novel selective endothelin ETA receptor antagonist, on blood pressure in normotensive and hypertensive rats

Vascular pharmacology, 2004-02, Vol.41 (1), p.27-34

2004

Volltextzugriff (PDF)

Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X(2/3) receptor function and exerts an analgesic effect in pain models

European journal of pharmacology, 2008-07, Vol.589 (1-3), p.98

2008

Volltextzugriff (PDF)

The role of extracellular Ca2+ in carbachol-induced tonic contraction of the pig detrusor smooth muscle

Naunyn-Schmiedeberg's archives of pharmacology, 1994-10, Vol.350 (4), p.398-402

1994

Volltextzugriff (PDF)

Effects of selective endothelin ETA receptor antagonists on endothelin-1-induced potentiation of cancer pain

European journal of pharmacology, 2004-05, Vol.492 (2-3), p.177-182

2004

Volltextzugriff (PDF)

Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X 2/3 receptor function and exerts an analgesic effect in pain models

European journal of pharmacology, 2008, Vol.589 (1), p.98-101

2008

Volltextzugriff (PDF)

Antianginal Effects of YM-16151–4 in Various Experimental Angina Models

Journal of cardiovascular pharmacology, 1993-05, Vol.21 (5), p.701-708

1993

Volltextzugriff (PDF)

Cardiovascular Effects of YM430, a 1, 4-Dihydropyridine Derivative with β-Adrenoceptor Blocking Activity, in Dogs and Rats

Biological and Pharmaceutical Bulletin, 1997/03/15, Vol.20(3), pp.230-236

1997

Volltextzugriff (PDF)

Inhibitory Effects of a Selective Endothelin-A Receptor Antagonist YM598 on Endothelin-1-induced Potentiation of Nociception in Formalin-induced and Prostate Cancer-induced Pain Models in Mice

Journal of cardiovascular pharmacology, 2004-11, Vol.44 Suppl 1 (Supplement 1), p.S479-S482

2004

Volltextzugriff (PDF)

ASSESSMENT OF METABOLITES-INDUCED QTC PROLONGATION RISK

Journal of pharmacological and toxicological methods, 2007-09, Vol.56 (2), p.e46-e46

2007

Volltextzugriff (PDF)

Effect of single oral administration of YM598, a novel selective endothelin ET A receptor antagonist, on blood pressure in normotensive and hypertensive rats

Vascular pharmacology, 2004, Vol.41 (1), p.27-34

2004

Volltextzugriff (PDF)

Effects of selective endothelin ET(A) receptor antagonists on endothelin-1-induced potentiation of cancer pain

European journal of pharmacology, 2004-05, Vol.492 (2-3), p.177-182

2004

Volltextzugriff (PDF)

Effect of the Potassium Channel Opener YM934 on the Contractile Response to Electrical Field Stimulation in Pig Detrusor Smooth Muscle

The Journal of urology, 1995-11, Vol.154 (5), p.1914-1920

1995

Volltextzugriff (PDF)

Hypotensive Effects of YM430, a 1, 4-Dihydropyridine Derivative, in Spontaneously Hypertensive Rats and Renal Hypertensive Dogs

The Japanese Journal of Pharmacology, 1997, Vol.73(2), pp.113-124

1997

Volltextzugriff (PDF)

Cardiovascular effects of YM-16151-4. a novel dihydropyridine derivative which possesses calcium entry blocking and selective β1-adrenoceptor blocking activities, in dogs

Japanese Journal of Pharmacology, 1988, Vol.46 (suppl), p.267-267

1988

Volltextzugriff (PDF)

Cardiovascular Effects of YM430, a 1, 4-Dihydropyridine Derivative with [beta]-Adrenoceptor Blocking Activity, in Dogs and Rats

Biological & pharmaceutical bulletin, 1997-03, Vol.20 (3), p.230

1997

Volltextzugriff (PDF)

Effect of the Potassium Channel Opener YM934 on the Contractile Response to Electrical Field Stimulation in Pig Detrusor Smooth Muscle

The Journal of urology, 1995-11, p.1914-1920

1995

Volltextzugriff (PDF)

Cardiovascular Effects of a Novel Calcium Entry Blocking and Selective prAdrenoceptor Blocking Agent, YM-16151–4, in Anesthetized and Conscious Dogs

Journal of cardiovascular pharmacology, 1992-01, Vol.19 (1), p.60-68

1992

Volltextzugriff (PDF)

Pharmacological properties of YM-26365, a low molecular weight, orally active renin inhibitor

European journal of pharmacology, 1994-12, Vol.271 (2), p.341-348

1994

Volltextzugriff (PDF)

Cardiovascular Effects of YM-16151–4: A Novel Calcium Entry Blocking and Selective β1-Adrenoceptor Blocking Agent in Rats and Dogs

Journal of cardiovascular pharmacology, 1993-08, Vol.22 (2), p.247-252

1993

Volltextzugriff (PDF)

Hypotensive Effects of YM430, a 1,4-Dihydropyridine Derivative, in Spontaneously Hypertensive Rats and Renal Hypertensive Dogs

Japanese journal of pharmacology, 1997, Vol.73 (2), p.113-124

1997

Volltextzugriff (PDF)

Anti-anginal effects of YM-16151-4, a novel calcium entry blocking agent with β1-adrenoceptor blocking activity, in vivo and in vitro experiments

Japanese Journal of Pharmacology, 1989, Vol.49 (suppl), p.251-251

1989

Volltextzugriff (PDF)

Anti-anginal effects of YM-16151-4, a novel calcium entry blocking agent with β1-adrenoceptor blocking activity, in vivo and in vitro experiments

Japanese journal of pharmacology, 1989, Vol.49, p.251-251

1989

Volltextzugriff (PDF)

Antianginal effects of YM430, a novel calcium entry-blocking and β-adrenoceptor-blocking agent in several experimental angina models

General pharmacology, 1997-10, Vol.29 (4), p.545-550

1997

Volltextzugriff (PDF)

K channel opening effects of YM099 in isolated tissues

Japanese Journal of Pharmacology, 1993, Vol.61 (suppl.1), p.255-255

1993

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(44)
Tagungsberichte
(1)

Sprache

Englisch
(40)
Japanisch
(13)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X2/3 receptor function and exerts an analgesic effect in pain models

Effect of single oral administration of YM598, a novel selective endothelin ETA receptor antagonist, on blood pressure in normotensive and hypertensive rats

Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X(2/3) receptor function and exerts an analgesic effect in pain models

The role of extracellular Ca2+ in carbachol-induced tonic contraction of the pig detrusor smooth muscle

Effects of selective endothelin ETA receptor antagonists on endothelin-1-induced potentiation of cancer pain

Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X 2/3 receptor function and exerts an analgesic effect in pain models

Antianginal Effects of YM-16151–4 in Various Experimental Angina Models

Cardiovascular Effects of YM430, a 1, 4-Dihydropyridine Derivative with β-Adrenoceptor Blocking Activity, in Dogs and Rats

Inhibitory Effects of a Selective Endothelin-A Receptor Antagonist YM598 on Endothelin-1-induced Potentiation of Nociception in Formalin-induced and Prostate Cancer-induced Pain Models in Mice

ASSESSMENT OF METABOLITES-INDUCED QTC PROLONGATION RISK

Effect of single oral administration of YM598, a novel selective endothelin ET A receptor antagonist, on blood pressure in normotensive and hypertensive rats

Effects of selective endothelin ET(A) receptor antagonists on endothelin-1-induced potentiation of cancer pain

Effect of the Potassium Channel Opener YM934 on the Contractile Response to Electrical Field Stimulation in Pig Detrusor Smooth Muscle

Hypotensive Effects of YM430, a 1, 4-Dihydropyridine Derivative, in Spontaneously Hypertensive Rats and Renal Hypertensive Dogs

Cardiovascular effects of YM-16151-4. a novel dihydropyridine derivative which possesses calcium entry blocking and selective β1-adrenoceptor blocking activities, in dogs

Cardiovascular Effects of YM430, a 1, 4-Dihydropyridine Derivative with [beta]-Adrenoceptor Blocking Activity, in Dogs and Rats

Effect of the Potassium Channel Opener YM934 on the Contractile Response to Electrical Field Stimulation in Pig Detrusor Smooth Muscle

Cardiovascular Effects of a Novel Calcium Entry Blocking and Selective prAdrenoceptor Blocking Agent, YM-16151–4, in Anesthetized and Conscious Dogs

Pharmacological properties of YM-26365, a low molecular weight, orally active renin inhibitor

Cardiovascular Effects of YM-16151–4: A Novel Calcium Entry Blocking and Selective β1-Adrenoceptor Blocking Agent in Rats and Dogs

Hypotensive Effects of YM430, a 1,4-Dihydropyridine Derivative, in Spontaneously Hypertensive Rats and Renal Hypertensive Dogs

Anti-anginal effects of YM-16151-4, a novel calcium entry blocking agent with β1-adrenoceptor blocking activity, in vivo and in vitro experiments

Anti-anginal effects of YM-16151-4, a novel calcium entry blocking agent with β1-adrenoceptor blocking activity, in vivo and in vitro experiments

Antianginal effects of YM430, a novel calcium entry-blocking and β-adrenoceptor-blocking agent in several experimental angina models

K channel opening effects of YM099 in isolated tissues

Suchergebnisse filtern